A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hematology
SPPLAASH
SPPLAASH Study : a Randomized Study Aiming at Evaluating the Incidence of Post Lumbar Puncture Headache (PLPH) With the Use of Atraumatic Needles in Hematology
2 other identifiers
interventional
68
1 country
2
Brief Summary
Lumbar punctures are implemented for the diagnosis of patients with hematologic symptoms as well as for the intrathecal chemotherapy injections. Post lumbar puncture headache is a common complication for patients and is characterized by the occurrence of a headache with an orthostatic component, with additional symptoms such as nausea. Some studies in neurology, anesthesia and gynecology have previously shown a decreased incidence for post lumbar puncture headache while using atraumatic needles as compared to standard needles. In this context, it is necessary to better document the incidence of post lumbar puncture headache with the use of atraumatic needles in hematologic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable leukemia
Started Aug 2017
Typical duration for not_applicable leukemia
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2017
CompletedFirst Posted
Study publicly available on registry
April 24, 2017
CompletedStudy Start
First participant enrolled
August 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2020
CompletedFebruary 8, 2022
February 1, 2022
3.2 years
April 20, 2017
February 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of headache
Incidence of patients with mild and severe headache within 5 days following lumbar puncture as evaluated by verbal rating scales (intensity score ≥4) will be reported.
5 days
Secondary Outcomes (3)
Intensity of headache
5 days
Duration of significant headache
5 days
Pain intensity
5 days
Study Arms (2)
Standard needle
ACTIVE COMPARATORPatients perform a spinal punction according to the usual practice, with a standard needle.
Atraumatic needle
EXPERIMENTALPatients perform a spinal punction according to the usual practice, with an atraumatic needle.
Interventions
Patients will perform a spinal punction with a standard needle, used in the usual practice. The standard needles have the following characteristics : BD 22 G x 3 ½ in, 90mm, Quincke spinal needle, Black hub. When more than 2 attempts for lumbar puncture fail, the investigator will proceed with standard techniques (BD 20G x 3 ½ in, Quincke spinal needle, 90mm, yellow hub). This is a failed lumbar puncture.
Patients will perform a spinal punction with an atraumatic needle, used in the hematological service of the CHU of Saint-Etienne. The atraumatic needles have the following characteristics : Vygon 24 G × 3 ½ in, 90mm, Whitacre Pencil Point Spinal Needle, Purple hub. When more than 2 attempts for lumbar puncture fail, the investigator will proceed with standard techniques (BD 20G x 3 ½ in, Quincke spinal needle, 90mm, yellow hub). This is a failed lumbar puncture.
Eligibility Criteria
You may qualify if:
- Patients with hematologic syndromes undergoing a diagnostic lumbar puncture
- Signed written informed consent form
- Patient affiliated to a social security regimen or beneficiary of the same
You may not qualify if:
- Any known contraindication for the lumbar puncture procedure: increased intracranial pressure, blood clotting disorder, thrombocytopenia
- Any known infection
- Patient with a Body Mass index \< 18 or Body Mass index \> 40
- Any patient that requires an ultrasound guided lumbar puncture
- Patient that underwent a lumbar puncture within 6 months
- Patient under guardianship or deprived of his liberty or any condition that may affect the patient's ability to understand and sign the informed consent (art. L.1121-6, L.112-7, L.1211-8, L.1211-9)
- Refusing participation
- Pregnancy or breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre Léon Bérard
Lyon, 69000, France
CHU de Saint-Etienne
Saint-Etienne, 42055, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Denis Guyotat, PhD
CHU de Saint-Etienne
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Neither patients know the needle used during the spinal punction, nor the person collecting the information.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2017
First Posted
April 24, 2017
Study Start
August 22, 2017
Primary Completion
October 20, 2020
Study Completion
October 31, 2020
Last Updated
February 8, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share